Goodwill Pharma Plc. has successfully completed a private placement and the stock exchange registration of the new shares

Goodwill Pharma Plc. has increased its share capital in the form of a private placement raising HUF 1.3 billion new capital from investors. The Budapest Stock Exchange registered the new shares in the Xtend category on December 20, 2023.

Goodwill Pharma Plc. is a Hungarian integrated pharmaceutical public limited company established in 1997. The Company has manufacturing capacity in Hungary and Serbia and sells products in 10 other countries through subsidiaries and distribution partners focusing on Central and Eastern Europe and the Balkans. The Company’s own-manufactured and licensed medicines and dietary supplements play a growing role in its sales activities.

Concorde MB Partners, as nominated advisor, has provided financial advisory to Godwill Pharma Plc. for the private placement and the registration of shares in the Xtend category of the Budapest Stock Exchange.

“Financial advisory is like heart surgery. You are looking for the best and not the cheapest expertise. We have found it at CMBP.” – Dr. Ferenc Jójárt, founder and CEO of Goodwill Pharma Plc.